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OBJECTIVE: To evaluate the protective effects of N-acetyl cysteine on the pancreas and kidney after pancreatic ischemia reper-
fusion injury in a rat model. 
METHODS AND MATERIALS: Pancreatic ischemia reperfusion was performed in Wistar rats for 1 hour. Revascularization was 
achieved followed by 4 h of reperfusion. A total of 24 animals were divided into four groups: Group 1: sham; Group 2: pancreatic 
ischemia reperfusion without treatment; Group 3: pancreatic ischemia reperfusion plus N-acetyl cysteine intravenously; and Group 
4: pancreatic ischemia reperfusion plus N-acetyl cysteine per os. Blood and tissue samples were collected after reperfusion. 
RESULTS: There were significant differences in amylase levels between Group 1 (6.11±0.55) and Group 2 (10.30±0.50) [p=0.0002] 
as well as between Group 2 (10.30±0.50) and Group 4 (7.82±0.38) [p=0.003]; creatinine levels between Group 1 (0.52 ± 0.07) and 
Group 2 (0.77±0.18) [p=0.035] as well as between Group 2 (0.77±0.18) and Group 3 (0.48±0.13) [p=0.012]; and pancreatic tissue 
thiobarbituric acid reactive substance levels between Group 1 (1.27±0.96) and Group 2 (2.60±3.01) [p=0.026] as well as between 
Group 2 (2.60±3.01) and Group 4 (0.52±0.56) [p=0.002]. A decrease in pancreatic tissue GST-α3 gene expression was observed 
in Group 2 in comparison to Group 1 (p =0.006), and an increase was observed in Groups 3 and 4 when compared to Group 2 (p= 
0.025 and p=0.010, respectively). 
CONCLUSION: This study provides evidence that N-acetyl cysteine has a beneficial effect on pancreatic ischemia reperfusion 
injury and renal function in a rat model. 
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INTRODUCTION
Simultaneous pancreas-kidney transplantation has 
become the first treatment option for type I diabetes 
patients  with  end  stage  renal  failure.1  Despite 
substantial advancements in surgical technique, better 
immunosuppressive protocols, and improvements in organ 
preservation solutions, ischemia reperfusion (I-R) injury 
remains one of the biggest obstacles in the field of solid 
organ transplantation.2 For pancreas transplantation, severe 
I-R injury provokes graft pancreatitis, which remains 
a frequent complication (35%) in the immediate post-
operative time and may contribute to graft loss and kidney 
injury.3,4 Indeed, restrictive donor selection criteria for 
pancreas transplantation have been applied to avoid acute 
graft pancreatitis, thus contributing to lower pancreas graft 
availability and fewer pancreas transplantations.
One of the principle findings in I-R injury is the 
deterioration of graft microcirculation. The microcirculatory 312
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derangements are accompanied by an increase in acinar cell 
apoptosis, and at a later stage, acinar cell necrosis. Different 
therapeutic strategies, such as nitric oxide donation and 
endothelin inhibition, antioxidant therapies, anti-adhesive 
strategies, ischemic preconditioning, inhibition of apoptosis, 
and anti-inflammatory treatment have been established to 
counteract the effects of I-R injury.2 
Free radical scavengers attenuate I-R injury by 
eliminating the reactive oxygen species (ROS) that are well 
known to play a major role in the progression of I-R injury-
induced graft damage.5,6 
N-acetyl cysteine (NAC) has been shown to improve 
pancreatic microcirculation alterations in experimental 
pancreas transplantation.7 NAC interferes with ROS 
production by inhibiting active granulocytes, and it acts as a 
scavenger and induces glutathione production.8 Also, little is 
known about the gene expression underlying these actions in 
pancreatic I-R injury, not only in the pancreas but also in the 
kidney. Glutathione-S-transferase (GST) enzymes provide 
protection against neutrophils and ROS by catalyzing the 
formation of glutathione conjugates as well as by eliminating 
peroxides during I-R injury.9 Therefore, analysis of GST 
gene expression in this condition should help to reveal the 
mechanisms by which NAC protects the pancreas during 
I-R injury.
The aim of this study was to evaluate the protective 
mechanisms of NAC in the pancreas and kidney after 
pancreatic I-R injury in a rat model.
METHODS AND MATERIALS
The experimental model protocol and animal handling 
as well as procedures were performed in accordance with 
Faculdade de Medicina da Universidade de São Paulo 
Committee of Ethics in Research. Before the procedure, all 
animals had a 12-hour fasting period except for water given 
ad libitum.
Twenty-four Wistar rats weighing 300-350 g were 
anesthetized using Ketalar®/xylazine solution (initial dose 
of 170 mg/kg). During the procedure, anesthesia was 
maintained by intraperitoneal infusion of Ketalar®/xylazine 
solution (dose of 85 mg/ kg/h) throughout the experiment. 
Animals were intubated using a 14-gauge catheter 
and connected to volume-controlled ventilation (Harvard 
ventilator). The right jugular vein was cannulated using 
PE-50 tubing.
Pancreatic ischemia-reperfusion model
A pancreatic I-R model was established as described 
elsewhere.10 Briefly, the abdomen was opened by a midline 
laparotomy. The stomach was turned up cranially by two 
stay sutures. The splenic pancreas portion was carefully 
separated from the stomach, and the short gastric vessels 
were ligated. The spleen was used as a grip to move the 
pancreatic tail to minimize pancreatic injury. Some arterial 
arcades from the inferior pancreaticoduodenal artery to the 
splenic artery were ligated. Thus, a complete pedunculated 
pancreatic tail by splenic vessels was achieved. A vascular 
clamp was applied to the splenic vessels. The pancreatic tail 
portion was submitted to ischemia for 1 h. After completing 
1 h of ischemia, the vascular clamp was removed, and 
pancreatic revascularization was achieved followed by 4 h of 
reperfusion. The abdominal wall remained closed during the 
I-R period. Blood and tissue samples (pancreas and kidney) 
were collected after 4 h of reperfusion.
Experimental protocol
The animals were divided into four groups:
·	 Group 1 (n=6): sham (submitted to operative procedure 
without pancreatic I-R);
·	 Group 2 (n=6): I-R (submitted to pancreatic I-R proce-
dure without treatment);
·	 Group 3 (n=6): I-R plus NAC – intravenously (iv): sub-
mitted to pancreatic I-R procedure and received NAC iv 
150 mg/kg 15 minutes before reperfusion and maintained 
at 50 mg/kg/h during 4 h of reperfusion; and
·	 Group 4 (n=6): I-R plus NAC – per os (po): submitted to 
pancreatic I-R procedure and received NAC 4800 mg/L 
ad libitum 48 h before the experiment.
Serum amylase and creatinine levels and pancreatic 
TBARS
Serum samples were assayed for amylase and creatinine 
levels.11 
Pancreatic tissue thiobarbituric acid reactive substance 
(TBARS) levels were determined as previously described.12 
Malondialdehyde (MDA) levels in the samples were 
determined to obtain a quantitative estimate of membrane 
lipid oxidative damage. MDA was assayed in terms of 
thiobarbituric acid reactive substances. Pancreas tissues 
(100 mg/mL) were homogenized in 1.15% KCl buffer and 
centrifuged at 14,000 x g for 20 min. The supernatant was 
then stored at -80°C. An aliquot of the supernatant was 
added to a reaction mixture of 1.5 mL 0.8% thiobarbituric 
acid, 200 µL 8.1% (v/v) SDS, 1.5 mL 20% (v/v) acetic acid, 
pH 3.5, and 300 µL distilled H2O and heated to 90°C for 45 
min. After cooling to room temperature, the samples were 
cleared by centrifugation at 10,000 x g for 10 min, and their 
absorbance was measured at 532 nm using malondialdehyde 313
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bis (dimethyl acetal) as an external standard. The quantity of 
lipid peroxides is reported in nmol malondialdehyde (MDA) 
equivalents/mg protein.
RNA isolation
Total RNA was isolated from pancreas and kidney using 
Trizol reagent (Invitrogen, Life Technologies, Gaithersburg, 
USA) according to the manufacturer’s instructions from 
fresh-frozen pancreas and kidney tissues from all groups. 
RNA quality assessment was analyzed with an aliquot of 
500 ng on a 1% agarose gel. Samples were kept at -80°C 
until processing by quantitative RT-PCR (qRT-PCR).
GST-α3 quantitative RT-PCR analysis
qRT-PCR analysis was performed in the Rotor-Gene 
RG-3000 (Corbett Research, Sidney, Australia) using 
the SuperScriptTM III Platinum® SYBR® Green One-Step 
qRT-PCR kit (Invitrogen, Life Technologies) with 100 
ng of total RNA and 0.2 mM sense/antisense primer per 
reaction, according to the manufacturer’s recommendations. 
The reaction was carried out under the following cycling 
conditions: 10 min at 50ºC and 5 min at 95ºC followed by 
35 cycles of 20 sec at 95ºC, 30 sec at 57ºC and 30 sec at 
72ºC. To verify amplification reaction specificity, melting 
curves were determined using the following parameters: 
72ºC ramping to 99°C at 0.2ºC/s. Primer sets were designed 
to amplify two separate intron-spanning regions, enabling 
assessment for possible genomic DNA contamination: 
GST-α3 sense 5´-GGC GGA TCT GGA TGA AAT AGT 
TCT-3´; GST-α3 antisense 5´-CAA CGA GAT AAT CTT 
GTC CAT GGC-3´; β-actin sense 5´-TGT CAC CAA CTG 
GGA CGA TA-3´; and β-actin antisense 5´-GGG GTG 
TTG AAG GTC TCA AA-3´. Primers were designed using 
the primer3_www.cgi v 0.2 program.13 Specificity of the 
product was ensured by melting point analysis and agarose 
gel electrophoresis to visualize the band for GST-α3 and 
β-actin with the corresponding sizes: 152 bp and 165 bp, 
respectively. RNA template concentrations (500 ng/µl, 100 
ng/µl, 20 ng/µl, 4 ng/µl and 0.8 ng/µl) were used to generate a 
standard curve to evaluate the amplification efficiency of the 
GST-α3 gene in comparison to β-actin. The RNA content of 
GST-α3 was determined as the number of transcripts relative 
to those of β-actin and additionally normalized to the mean 
value of control pancreas and kidney. Relative quantification 
was calculated using a mathematical model based on GST-α3 
and β-actin gene amplification efficiency.14 All samples were 
analyzed in duplicate.
Statistical Analysis
The results were expressed as arithmetic mean and 
standard deviation (sd). Collected data were stored in a 
computer, plotted using spreadsheets in the Excel program 
(Microsoft, Seattle, WA, USA) and statistically analyzed 
using GraphPad Prism 2.01 (San Diego, CA, USA), JMP 
Starter 5.1.1. (SAS Institute Inc., Heidelberg, Germany) 
and SigmaStat 2.03 Statistical (Systat Software Inc., Point 
Richmond, USA). The differences between the mean values 
were compared by Student´s t-test for unpaired data and 
analysis of variance (ANOVA) with comparisons using the 
Kruskal-Wallis test based on rank sum. A P value of less 
than 0.05 was considered statistically significant.
RESULTS
Serum amylase levels were 6.11±0.55 mg/mL/min, 
10.30±0.50 mg/mL/min, 9.77±1.24 mg/mL/min and 
7.82±0.38 mg/mL/min in Groups 1, 2, 3 and 4, respectively. 
There was an increase in serum amylase when comparing 
Group 1 with Group 2 (p=0.0002) and a decrease when 
comparing Group 2 with Group 4 (p=0.003) (Table 1).
Serum creatinine levels were 0.52±0.07 mg/dL, 
0.77±0.18 mg/dL, 0.48±0.13 mg/dL and 0.83±0.25 mg/dL 
for Groups 1, 2, 3 and 4, respectively. There was an increase 
in serum creatinine when comparing Group 1 with Group 
2 (p=0.035) and a decrease when comparing Group 2 with 
Group 3 (p=0.012) (Table 1).
Pancreatic tissue TBARS levels were 1.27±0.96 nmol 
TBARS/mg protein, 2.60±3.01 nmol TBARS/mg protein, 
1.44±1.61 nmol TBARS/mg protein, and 0.52±0.56 nmol 
Table 1 - Amylase and creatinine serum levels and TBARS pancreatic tissue expressed as mean±standard deviation.
Group Amylase (mg/mL/min) Creatinine (mg/dL) TBARS (nmol/protein/mg)
1 6.11 ± 0.55a 0.52 ± 0.07c 1.27 ± 0.96e
2 10.3 ± 0.5a,b 0.77 ± 0.18c,d 2.60 ± 3.01e,f
3 9.77 ± 1.24 0.48 ± 0.13d 1.44 ± 1.61
4 7.82 ± 0.38b 0.83 ± 0.25 0.52 ± 0.56f
a- p=0.0002; b- p=0.003; c- p=0.012; d- p=0.03; e- p=0.0023; f- p=0.026314
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TBARS/mg protein for Groups 1, 2, 3 and 4, respectively. 
There was an increase in pancreatic tissue TBARS levels 
when comparing Group 1 with Group 2 (p=0.026) and a 
decrease when comparing Group 2 with Group 4 (p=0.002) 
(Table 1).
A decrease in pancreatic tissue GST-α3 gene expression 
was observed in Group 2 compared to Group 1 (p=0.006), 
and an increase was observed in Groups 3 (p=0.025) and 4 
(p=0.010) when compared to Group 2 (Figure 1). 
An increase in renal tissue GST-α3 gene expression was 
observed in Group 2 compared to Group 1 (p=0.037), and a 
decrease was observed in Group 4 when compared to Group 
2 (p=0.010) (Figure 2). 
DISCUSSION
NAC, a precursor of l-cysteine and reduced glutathione 
(GSH), affects a variety of biological and pathological 
processes, as it is a source of sulfhydryl groups in cells and 
a ROS scavenger. Numerous studies have shown a protective 
effect of free radical scavengers such as NAC, glutathione, 
and others on I-R injury.15 
In our experiment, pancreatic I-R injury promoted 
hyperamylasemia. Pancreatic I-R injury has been known 
to produce hyperamylasemia probably due to ROS 
damage. Tamura et al. suggested that the active oxygen 
species that are generated by short-term pancreatic 
ischemia and reperfusion injure the endothelium and cause 
hyperamylasemia. Inhibition of the increase in serum 
amylase concentration by pretreatment with a scavenger 
of active oxygen, superoxide dismutase, suggests that the 
active oxygen species are involved in the pathogenesis of 
acute pancreatitis.16 Our results showed that NAC given 48 
h before I-R induction reduced the amylasemia. However, 
iv NAC given during pancreatic I-R induction was unable to 
reduce the amylasemia. 
It is known that many immediate-early genes are 
expressed during I-R injury.17,18 We demonstrated that 
reduced pancreatic GST-α3 gene expression may be due 
to blood flow interruption with a subsequent impairment 
of antioxidant protective mechanisms. However, a renal 
GST-α3 gene expression increase by itself was unable to 
preserve renal function as demonstrated by creatinine levels 
(Table 1). Interestingly, renal function was improved only 
by iv NAC. This protective effect may be due to a higher 
blood level achieved by iv NAC and its direct hydroxyl 
radical scavenging ability.19,20 In a chronic renal failure 
model, experimental NAC administration has been shown 
to have a renal protective effect attributable to lower lipid 
peroxidation levels.21 
Several antioxidants (e.g., mannitol, allopurinol, 
N-acetyl-cysteine) were shown to reduce the negative 
effect of xanthine oxidase on remote organs by scavenging 
hydroxyl radicals and reducing the oxidant-derived 
injury.22,23 Khoury et al. examined the effect of I-R of the 
rat pancreas on rat kidney function in an isolated organ 
model. The authors assessed whether the level of oxidative 
stress detected during pancreas I-R would correlate with 
the use of mannitol (an antioxidant and a clinically used 
compound) in such occasions, i.e., the prevention of kidney 
dysfunction. They showed that ischemia/reperfusion of the 
rat pancreas evokes immediate renal dysfunction and that 
kidney oxidant-antioxidant balance is disturbed; however, 
this can be prevented with mannitol.24
NAC also may exert its antioxidant effects by reducing 
lipid peroxidation, thus attenuating membrane damage 
Figure 1 - Box diagram comparing relative GST-α3 mRNA expression 
levels in pancreas tissues in Groups 1, 2, 3 and 4. The horizontal line within 
the box plot represents the median value, the box plot limits refer to 25th to 
75th percentiles, and the box plot bars include the 10th to 90th percentiles 
for mRNA levels. 
Figure 2 - Box diagram comparing relative GST-α3 mRNA expression 
levels in kidney tissues in Groups 1, 2, 3 and 4. The horizontal line within 
the box plot represents the median value, the box plot limits refer to 25th to 
75th percentiles, and the box plot bars include the 10th to 90th percentiles 
for mRNA levels.315
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from ROS. It was associated with pancreatic GST-α3 gene 
expression. In our experiment, NAC provided effective 
pancreatic protection against I-R injury, as revealed by lower 
serum TBARS and amylase levels, an increase in GST-α3 
expression and a decrease in pancreatic tissue TBARS. 
However, it did not recover renal function nor increase renal 
GST-α3 gene expression. 
There are numerous potential mechanisms of action by 
which NAC may exert protective effects against I-R injury. 
These potential protective effects of NAC have been tested 
in several animal models, including models in which animals 
were subjected to hepatic ischemia with hepatic vascular 
inflow occlusion followed by reperfusion and in animals 
that were subjected to liver transplantation. Overall, these 
studies have demonstrated that NAC was able to maintain 
hepatic GSH levels when administered prior to I-R and was 
effective at replenishing depleted glutathione stores rapidly 
when administered after I-R.25-27
The oxidative stress generated by the imbalance between 
ROS and the endogenous antioxidant forces is now known 
to be closely related to renal I-R injury. In addition to being 
the precursor of L-cysteine and glutathione reductase, NAC 
acts as a superoxide scavenger and is capable of tripling 
endothelial NOS expression as well as increasing NO 
bioavailability. 28,29 N-acetylcysteine may also be protective 
through its influence on the metabolism of NO, which is 
produced in large amounts in the setting of liver I-R injury 
due to the expression of inducible NO synthetase (iNOS).30
In  summary,  our  study  demonstrates  that  NAC 
administration ameliorates the pancreatic I-R injury 
observed 4 h after reperfusion. Although we have shown the 
beneficial action of NAC in pancreatic I-R injury, further 
studies are still needed to support these findings.
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